India  

Russia approached GOI seeking help in manufacturing, phase 3 studies of COVID vaccine: NITI Aayog

Video Credit: ANI - Duration: 01:36s - Published
Russia approached GOI seeking help in manufacturing, phase 3 studies of COVID vaccine: NITI Aayog

Russia approached GOI seeking help in manufacturing, phase 3 studies of COVID vaccine: NITI Aayog

NITI Aayog member Dr. VK Paul during the Health Ministry briefing said that the vaccine developed by Russia has been under consideration of the country.

Dr VK Paul said, "The vaccine developed by Russia has been under consideration of the country.

Government of Russia approached our government and sought help on two counts- to consider its manufacturing through our network of companies, and phase 3 studies in India." He further said that the government of India attaches great importance to this offer of partnership from a very special friend of this nation, and on both the tracks there has been significant movement.


You Might Like


Related videos from verified sources

The scientist behind Russia's 'Sputnik' vaccine [Video]

The scientist behind Russia's 'Sputnik' vaccine

Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the..

Credit: Reuters Studio     Duration: 02:16Published
Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News [Video]

Russian Direct investment fund partners with Dr. Reddy's for Sputnik V trials in India|Oneindia News

Dr Reddy's and the Russian Direct Investment Fund (RDIF) have agreed to conduct clinical trials and distribute 100 million doses of Russia's Sputnik V Covid-19 vaccine in India. The RDIF is Russia's..

Credit: Oneindia     Duration: 01:03Published
Sputnik V explainer: How Russia's coronavirus vaccine works [Video]

Sputnik V explainer: How Russia's coronavirus vaccine works

MOSCOW — Russia on August 11 became the first country in the world to approve a vaccine for SARS-CoV-2, the novel coronavirus that causes COVID-19. Now the first batch of the vaccine is ready for..

Credit: TomoNews US     Duration: 02:57Published